Abstract:Understanding how variations in the plasma and brain proteome contribute to multiple sclerosis susceptibility can provide important insights to guide drug repurposing and therapeutic development for the disease. However, the role of genetically predicted protein abundance in multiple sclerosis remains largely unknown. Integrating plasma proteomics (n = 3301) and brain proteomics (n = 376 discovery; n = 152 replication) into multiple sclerosis genome-wide association studies (n = 14 802 cases and 26 703 controls), we employed summary-based methods to identify candidate proteins involved in multiple sclerosis susceptibility. Next, we evaluated associations of the corresponding genes with multiple sclerosis at tissue-level using large gene expression quantitative trait data from whole-blood (n = 31 684) and brain (n = 1194) tissue. Further, to assess transcriptional profiles for candidate proteins at cell-level, we examined gene expression patterns in immune cell types (Dataset 1: n = 73 cases and 97 controls; Dataset 2: n = 31 cases and 31 controls) for identified plasma proteins, and in brain cell types (Dataset 1: n = 4 cases and 5 controls; Dataset 2: n = 5 cases and 3 controls) for identified brain proteins. In a longitudinal multiple sclerosis cohort (n = 203 cases followed up to 15 years), we also assessed the corresponding gene-level associations with the outcome of disability worsening. We identified 39 novel proteins associated with multiple sclerosis risk. Based on five identified plasma proteins, four available corresponding gene candidates showed consistent associations with multiple sclerosis risk in whole-blood, and we found TAPBPL upregulation in multiple sclerosis B cells, CD8+ T cells and natural killer cells compared with controls. Among the 34 candidate brain proteins, 18 were replicated in a smaller cohort and 14 of 21 available corresponding gene candidates also showed consistent associations with multiple sclerosis risk in brain tissue. In cell-specific analysis, six identified brain candidates showed consistent differential gene expression in neuron and oligodendrocyte cell clusters. Based on the 39 protein-coding genes, we found 23 genes that were associated with disability worsening in multiple sclerosis cases. The findings present a set of candidate protein biomarkers for multiple sclerosis, reinforced by high concordance in downstream transcriptomics findings at tissue-level. This study also highlights the heterogeneity of cell-specific transcriptional profiles for the identified proteins and that numerous candidates were also implicated in disease progression. Together, these findings can serve as an important anchor for future studies of disease mechanisms and therapeutic development.

GWAS highlights the neuronal contribution to multiple sclerosis susceptibility

Gene-Based Tests of a Genome-Wide Association Study Dataset Highlight Novel Multiple Sclerosis Risk Genes

Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Utilising multi-large omics data to elucidate biological mechanisms within multiple sclerosis genetic susceptibly loci

Brain proteome‐wide association study linking‐genes in multiple sclerosis pathogenesis

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Locus for severity implicates CNS resilience in progression of multiple sclerosis

Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis

[New gene map for multiple sclerosis]

Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population

Functional relevance for multiple sclerosis-associated genetic variants

Multiple Sclerosis Risk Pathways Differ in Caucasian and Chinese Populations

Integration of Alzheimer's Disease Genetics and Myeloid Cell Genomics Identifies Novel Causal Variants, Regulatory Elements, Genes and Pathways

Integration of Alzheimer’s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes

Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways

Examination of the shared genetic architecture between multiple sclerosis and systemic lupus erythematosus facilitates discovery of novel lupus risk loci

Integration of Alzheimer’s Disease Genetics and Myeloid Genomics Reveals Novel Disease Risk Mechanisms

Genome-wide identification and analysis of the eQTL lncRNAs in multiple sclerosis based on RNA-seq data

Novel Plasma and Brain Proteins That Are Implicated in Multiple Sclerosis.

Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system